Publications from my research and collaborations include
Fohner, AE. D Brackman, KM Giacomini, TE Klein. “PharmGKB summary: very important pharmacogene ABCG2.” Pharmacogenetics and Genomics. in press.
Fohner, A.E. N.A Garrison, M.A Austin, W Burke. “Reply to ‘health effects of the CPT1A P479L variant: responsible public health action.” Genetics in Medicine. In press. read it here: http://rdcu.be/uUy0
Fohner, A.E. A Sparreboom, R.B Altman, T.A Klein. “PharmGKB summary: macrolide antibiotics pharmacokinetics/pharmacodynamics pathway.” Pharmacogenetics and Genomics. In press.
Fohner, A.E. N.A Garrison, M.A Austin, W Burke. “Carnitine Palmitoyltransferase 1A P479L and Infant Death: Policy Implications of Emerging Data.” Genetics in Medicine. In press.
Fohner, A.E. E.M McDonagh, J.P Clancy, R.B Altman, T.A Klein. “PharmGKB summary: ivacaftor pharmacokinetics/pharmacodynamics pathway.” Pharmacogenetics and Genomics. 2017 Jan;27(1):39-42.
Fohner AE, Wang Z, Yracheta J, O’Brien D, Hopkins SE, Black J, Philip J, Wiener HW, Tiwari HK, Stapleton PL, Tsai JM, Thornton TA, Boyer BB, Thummel KE. “Genetics, Diet, and Season Are Associated with Serum 25-Hydroxycholecalciferol Concentration in a Yup’ik Study Population from Southwestern Alaska.” J. Nutr. dos: 10.3945/jn115.223388.
Shirasaka Y, Chaudhry AS, McDonald M, Prasad B, Wong T, Calamia JC, Fohner A, Thornton TA, Isoherranen N, Unadkat JD, Rettie AE, Schuetz EG, Thummel KE. “Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content.” Pharmacogenomics J. 2015 Sep 1. PMID: 26323597
Chaudhry AS, Prasad B, Shirasaka Y, Fohner A, Finkelstein D, Fan Y, Wang S, Wu G, Aklillu E, Sim SC, Thummel KE, Schuetz EG. “The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles.” Drug Metab Dispos. 2015 Aug;43(8):1226-35. PMID: 26021325
Fohner AE, Robinson R, Yracheta J, Dillard DA, Schilling B, Khan B, Hopkins S, Boyer BB, Black J, Wiener H, Tiwari HK, Gordon A, Nickerson D, Tsai JM, Farin FM, Thornton TA, Rettie AE, Tummel KE. “Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.” Pharmacogenet Genomics. 2015 Jul;25(7):343-53. PMID: 25946405
Fohner A, Muzquiz LI, Austin MA, Gaedigk A, Gordon A, Thornton T, Rieder MJ, Pershouse MA, Putnam EA, Howlett K, Beatty P, Thummel KE, Woodahl EL. “Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.” Pharmacogenet Genomics. 2013 Aug;23(8):403-14. PMID: 23778323
Nguyen KD, Fohner A, Booker JD, Dong D, Krensky AM, and Nadeau KC. “XCL1 Enhances Regulatory Activities of CD4(+)CD25(High)CD127(Low/-) T Cells In Human Allergic Asthma”. J Immunol. 2008 Oct 15;181(8):5386-95. PMID: 18832695
Nguyen KD, Vanichsarn C, Fohner A, and Nadeau KC. “Selective Deregulation In Chemokine Signaling Pathways of CD4(+)CD25(Hi)CD127(Lo/-) Regulatory T Cells In Human Allergic Asthma”. J Allergy Clin Immunol. 2009 Apr;123(4):933-9.e10. PMID: 19152963
